SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMNR - Immune Response -- Ignore unavailable to you. Want to Upgrade?


To: Alex Glavinos who wrote (1279)2/7/1999 9:46:00 PM
From: Captain Jack  Read Replies (1) | Respond to of 1510
 
Alex--- true most biotechs have been quiet and little price movement for sometime. IMNR is in a nice range but IMO should be in the 13 - 14 range until some of the expected news is reported. Look at what you reported again;
Changes to "IMNR: Immune Response Corp." found on Jan 20:

1.1999

January: * Received Second $5 Million Quarterly Payment from Agouron Pharmaceuticals,
Inc.

Jan 7:

1.December: * Announced Results from Phase IIb Clinical Trial for Rheumatoid Arthritis. *
Received U.S. Patent on Rheumatoid Arthritis and Multiple Sclerosis Technologies.

November: * Announced Publication of Phase II Trial Results for Rheumatoid Arthritis
Treatment.

October: * Announced REMUNE™ clinical data from Phase II Combination Drug
Trial. * Received First $5 Million Quarterly Payment from Agouron Pharmaceuticals, Inc.

2.* Began Additional Combination Drug Trial with REMUNE in the United States.

Sep 22:

1.September: * Treated First Patient in Phase Ib Clinical Trial for Colon Cancer.

Aug 27:

1.August: * Announced Publication of Results from Thailand Clinical Trial using
REMUNE™. * Announced Initiation of Open-Label Clinical Trial of Rheumatoid
Arthritits Treatment.

The last few months have been VERY positive. The only question I have not been able to get an answer to with certainty is "where is the AGPH agreement/assistance at this time and into the future?". WLA bought AGPH for their pipeline and IMNR is a part of that!

John